Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOT65+ trial in older patients with advanced gastric or esophagogastric junction cancer
2006-006936-24Phase 2Active
- Sponsor
- Krankenhaus Nordwest
- Start
- May 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of docetaxel, oxaliplatin, fluorouracil and folinic acid in gastric adenocarcinoma and gastroesophageal adenocarcinoma, sponsored by Krankenhaus Nordwest. Primary endpoint: response rate. Started May 2007; status: active.
02
Drugs
docetaxeloxaliplatinfluorouracilfolinic acid
03
Conditions
gastric adenocarcinomagastroesophageal adenocarcinoma
Beyond the preview
Go deeper on 2006-006936-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006936-24.